Aurora Cannabis Inc. has signed a deal to buy Whistler Medical Marijuana Corp. in an all-stock deal worth up to $175 million, including certain milestone payments.
Edmonton-based Aurora says the acquisition of the privately held company is expected to provide it with a suite of premium and organic certified products.
Get breaking National news
Whistler operates two indoor licensed production facilities, include one in Whistler, B.C., and another a short drive from the resort town.
READ MORE: Aurora Cannabis to acquire Mexican company following partnership deal
Once the second location reaches full capacity, the facilities are expected to have a combined production capacity of over 5,000 kilograms per year.
- Nova Scotia rolls out new cannabis rules, but Mi’kmaq group defends economic rights
- Teen accused in shooting death of Toronto police officer appears in court
- RCMP cannabis raids won’t ‘hamper’ N.B. First Nations pot sale discussions: minister
- Quebec cannabis use is dropping, but how much depends on age range
-
![]()
Province considers safety changes at cannabis stores -
![]()
Health Matters: Talking to teens about the risks of cannabis poisoning -
![]()
Atlantic Mi’kmaq communities at odds with Nova Scotia government over cannabis -
![]()
N.S. Premier Tim Houston responds to tensions between RCMP and First Nations following recent cannabis raid
The deal is subject to customary closing conditions, as well as third party and regulatory approvals.
Shares in Aurora closed at $8.47 on the Toronto Stock Exchange on Friday.
READ MORE: Aurora Cannabis ramping up production but recreational pot shortages will likely linger
Comments
Want to discuss? Please read our Commenting Policy first.